Literature DB >> 28464285

Elimination of GPR146-mediated antiviral function through IRF3/HES1-signalling pathway.

Hongjun Huang1, Na Zhang1, Qingqing Xiong1, Ruoyu Chen1, Chengfei Zhang1, Ning Wang1, Li Wang1, Hua Ren1, Mingyao Liu1, Min Qian1, Bing Du1.   

Abstract

As the most important host defence against viral infection, interferon (IFN) stimulates hundreds of antiviral genes (ISGs) that together establish an 'antiviral state'. However, the antiviral function of most ISGs in viral infection still need further exploration. Here, we demonstrated that the expression of G-protein-coupled receptor 146 (GPR146) is highly increased by both IFN-β and IFN-γ in a signal transducer and activator of transcription 1-dependent signalling pathway. Most importantly, overexpression of GPR146 protects the host cells from vesicular stomatitis virus and Newcastle disease virus infection but not from infection by herpes simplex virus. In contrast, the virus-induced IFN-β production changed little in Gpr146-knockout cells. Furthermore, the Gpr146-deficient mice showed similar susceptibility to wild-type mice with vesicular stomatitis virus infection. Interestingly, the expression of GPR146 in virus-infected cells was strikingly reduced and can partially explain why the viral infection was little influenced in Gpr146-knockout mice. Surprisingly, virus-activated IFN regulatory factor 3 (IRF3) signalling not only induces the expression of IFN but also represses GPR146 expression through HES1 (hairy and enhancer of split-1)-mediated transcriptional activity to establish a dynamic equilibrium between pro-viral and antiviral stages in host cells. Taken together, these data reveal the antiviral role of GPR146 in fighting viral infection although the GPR146-mediated protection is eliminated by IRF3/HES1-signalling, which suggests a potential therapeutic significance of both GPR146 and HES1 signalling in viral infection.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  GPR146; HES1; IRF3; ISGs; viral infection

Mesh:

Substances:

Year:  2017        PMID: 28464285      PMCID: PMC5543731          DOI: 10.1111/imm.12752

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  Nine new human Rhodopsin family G-protein coupled receptors: identification, sequence characterisation and evolutionary relationship.

Authors:  David E I Gloriam; Helgi B Schiöth; Robert Fredriksson
Journal:  Biochim Biophys Acta       Date:  2005-04-15

Review 4.  Innate immune sensing and signaling of cytosolic nucleic acids.

Authors:  Jiaxi Wu; Zhijian J Chen
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

5.  P2Y(6) agonist uridine 5'-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment.

Authors:  Zhi Zhang; Ziqiang Wang; Hua Ren; Miaomiao Yue; Kan Huang; Hongjie Gu; Mingyao Liu; Bing Du; Min Qian
Journal:  J Immunol       Date:  2011-03-28       Impact factor: 5.422

6.  Rapid susceptibility testing for herpes simplex virus type 1 using real-time PCR.

Authors:  Martha T van der Beek; Eric C J Claas; Caroline S van der Blij-de Brouwer; Florence Morfin; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Virol       Date:  2012-09-29       Impact factor: 3.168

7.  Influenza virus-host interactome screen as a platform for antiviral drug development.

Authors:  Tokiko Watanabe; Eiryo Kawakami; Jason E Shoemaker; Tiago J S Lopes; Yukiko Matsuoka; Yuriko Tomita; Hiroko Kozuka-Hata; Takeo Gorai; Tomoko Kuwahara; Eiji Takeda; Atsushi Nagata; Ryo Takano; Maki Kiso; Makoto Yamashita; Yuko Sakai-Tagawa; Hiroaki Katsura; Naoki Nonaka; Hiroko Fujii; Ken Fujii; Yukihiko Sugita; Takeshi Noda; Hideo Goto; Satoshi Fukuyama; Shinji Watanabe; Gabriele Neumann; Masaaki Oyama; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

8.  Evidence for an interaction between proinsulin C-peptide and GPR146.

Authors:  Gina L C Yosten; Grant R Kolar; Lauren J Redlinger; Willis K Samson
Journal:  J Endocrinol       Date:  2013-07-11       Impact factor: 4.286

Review 9.  Metabolism meets immunity: The role of free fatty acid receptors in the immune system.

Authors:  Elisa Alvarez-Curto; Graeme Milligan
Journal:  Biochem Pharmacol       Date:  2016-03-19       Impact factor: 5.858

10.  The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation.

Authors:  Yingli Shang; Maddalena Coppo; Teng He; Fei Ning; Li Yu; Lan Kang; Bin Zhang; Chanyang Ju; Yu Qiao; Baohong Zhao; Manfred Gessler; Inez Rogatsky; Xiaoyu Hu
Journal:  Nat Immunol       Date:  2016-06-20       Impact factor: 25.606

View more
  3 in total

1.  Loss of Function Mutation in ELF4 Causes Autoinflammatory and Immunodeficiency Disease in Human.

Authors:  Gan Sun; Luyao Qiu; Lang Yu; Yunfei An; Yuan Ding; Lina Zhou; Junfeng Wu; Xi Yang; Zhiyong Zhang; Xuemei Tang; Huawei Xia; Lili Cao; Fuping You; Xiaodong Zhao; Hongqiang Du
Journal:  J Clin Immunol       Date:  2022-03-09       Impact factor: 8.542

2.  Whitefly HES1 binds to the intergenic region of Tomato yellow leaf curl China virus and promotes viral gene transcription.

Authors:  Yu-Meng Wang; Ya-Zhou He; Xin-Tong Ye; Wen-Ze He; Shu-Sheng Liu; Xiao-Wei Wang
Journal:  Virology       Date:  2020-01-21       Impact factor: 3.616

3.  Metabolite-Sensing G Protein Coupled Receptor TGR5 Protects Host From Viral Infection Through Amplifying Type I Interferon Responses.

Authors:  Qingqing Xiong; Hongjun Huang; Ning Wang; Ruoyu Chen; Naiyang Chen; Honghui Han; Qin Wang; Stefan Siwko; Mingyao Liu; Min Qian; Bing Du
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.